leadf
logo-loader
LSE:DDDD

4D pharma plc

Receive alerts
Market:
LSE
Market Cap:
£191.83 m
Price
146.00 GBX
Change
-7.59%
52 weeks high
180.00
52 weeks low
23.50

In brief

4D are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics.

Snapshot

Working in the emerging area of the human microbiome, the company has developed candidates in cancer, gastrointestinal and respiratory ailments, and autoimmune disease